IRF8 and neoplasm: This suppression of IRF8 hinders T cell activation and infiltration, thereby diminishing the anti-tumor immune response.209 In murine models, overexpression of IRF8 has been shown to restrict MDSC accumulation, mitigate the immunosuppression exerted by MDSCs, counteract their tumor-promoting effects, and improve the effectiveness of immunotherapies.208